Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of Candida albicans
- PMID: 39770352
- PMCID: PMC11678012
- DOI: 10.3390/pathogens13121092
Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of Candida albicans
Abstract
Today, Candida albicans is still the most common cause of both local and life-threatening systemic candidiasis. The spread of resistant fungal strains has resulted in an urgent need to search for new promising antimycotics. Here, we investigated the antifungal action of the tobacco defensin NaD1 against susceptible and resistant to azoles and echinocandins strains of C. albicans. We demonstrated that NaD1 was equally effective and fungicidal against all tested strains. The MIC and MFC values were 6.25 and 12.5 µM, respectively. We showed for the first time that NaD1 could act synergistically not only with caspofungin but also with human host defense antimicrobial peptides cathelicidin LL-37 and β-defensin-2 (HBD2) against susceptible and resistant fungal strains. Using flow cytometry, we demonstrated that NaD1 in combinations with LL-37 or HBD2 can reinforce each other by enhancing membrane disruption. Using the Caco-2 cell monolayer model, we demonstrated that NaD1 impaired the adhesion of C. albicans cells to the human epithelium. Moreover, NaD1 inhibited the formation of fungal biofilms in Sabouraud broth and less markedly in nutrient-rich RPMI-1640 medium, and enhanced the antibiofilm activity of caspofungin. Thus, we hypothesized that NaD1 might affect the development of candidiasis in vivo, including that caused by resistant fungal strains.
Keywords: Candida albicans; adherence; biofilms; candidiasis; caspofungin; clinical isolates; human cathelicidin LL-37; human β-defensin 2 (HBD2); membrane-disrupting activity; plant defensins; resistance; synergism; tobacco NaD1.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.Peptides. 2016 Jan;75:71-9. doi: 10.1016/j.peptides.2015.11.001. Epub 2015 Nov 28. Peptides. 2016. PMID: 26592804
-
Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures.PLoS One. 2015 Aug 6;10(8):e0132701. doi: 10.1371/journal.pone.0132701. eCollection 2015. PLoS One. 2015. PMID: 26248029 Free PMC article.
-
Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.Antimicrob Agents Chemother. 2018 May 25;62(6):e00111-18. doi: 10.1128/AAC.00111-18. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29610196 Free PMC article.
-
Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Braz J Microbiol. 2022 Sep;53(3):1101-1113. doi: 10.1007/s42770-022-00739-9. Epub 2022 Mar 29. Braz J Microbiol. 2022. PMID: 35352319 Free PMC article. Review.
-
Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi.Appl Microbiol Biotechnol. 2024 Mar 27;108(1):277. doi: 10.1007/s00253-024-13118-1. Appl Microbiol Biotechnol. 2024. PMID: 38536496 Free PMC article. Review.
Cited by
-
Nicotianin-I: A Tobacco Floral Nectar Peptide with Anticandidal Activity.ACS Omega. 2025 May 14;10(20):20213-20225. doi: 10.1021/acsomega.4c10806. eCollection 2025 May 27. ACS Omega. 2025. PMID: 40454052 Free PMC article.
References
-
- World Health Organization WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. [(accessed on 28 November 2024)]. Available online: https://www.who.int/publications/i/item/9789240060241.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources